Literature DB >> 10556568

Proteinase inhibitors from desert locust, Schistocerca gregaria: engineering of both P(1) and P(1)' residues converts a potent chymotrypsin inhibitor to a potent trypsin inhibitor.

Z Malik1, S Amir, G Pál, Z Buzás, E Várallyay, J Antal, Z Szilágyi, K Vékey, B Asbóth, A Patthy, L Gráf.   

Abstract

Two peptides, SGCI and SGTI, that inhibited chymotrypsin and trypsin, respectively, were isolated from the haemolymph of Schistocerca gregaria. Their primary structures were found to be identical with SGP-2 and SGP-1, two of a series of peptides isolated from ovaries of the same species (A. Hamdaoui et al., FEBS Lett. 422 (1998) 74-78). All these peptides are composed of 35-36 amino acid residues and contain three homologous disulfide bridges. The residues imparting specificity to SGCI and SGTI were identified as Leu-30 and Arg-29, respectively. The peptides were synthesised by solid-phase peptide synthesis, and the synthetic ones displayed the same inhibition as the natural forms: SGCI is a strong inhibitor of chymotrypsin (K(i) = 6.2 x 10(-12) M), and SGTI is a rather weak inhibitor of trypsin (K(i) = 2.1 x 10(-7) M). The replacement of P(1) then P(1)' residues of SGCI with trypsin-specific residues increased affinity towards trypsin 3600- and 1100-fold, respectively, thus SGCI was converted to a strong trypsin inhibitor (K(i) = 5.0 x 10(-12) M) that retained some inhibitory affinity towards chymotrypsin (K(i) = 3.5 x 10(-8) M). The documented role of both P(1) and P(1)' highlights the importance of S(1)'P(1)' interactions in enzyme-inhibitor complexes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556568     DOI: 10.1016/s0167-4838(99)00167-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  High affinity small protein inhibitors of human chymotrypsin C (CTRC) selected by phage display reveal unusual preference for P4' acidic residues.

Authors:  András Szabó; Dávid Héja; Dávid Szakács; Katalin Zboray; Katalin A Kékesi; Evette S Radisky; Miklós Sahin-Tóth; Gábor Pál
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

2.  Characterization of two novel pacifastin-like peptide precursor isoforms in the desert locust (Schistocerca gregaria): cDNA cloning, functional analysis and real-time RT-PCR gene expression studies.

Authors:  Gert Simonet; Bert Breugelmans; Paul Proost; Ilse Claeys; Jozef Van Damme; Arnold De Loof; Jozef Vanden Broeck
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

3.  Monospecific inhibitors show that both mannan-binding lectin-associated serine protease-1 (MASP-1) and -2 Are essential for lectin pathway activation and reveal structural plasticity of MASP-2.

Authors:  Dávid Héja; Veronika Harmat; Krisztián Fodor; Matthias Wilmanns; József Dobó; Katalin A Kékesi; Péter Závodszky; Péter Gál; Gábor Pál
Journal:  J Biol Chem       Date:  2012-04-16       Impact factor: 5.157

4.  Arg236 in human chymotrypsin B2 (CTRB2) is a key determinant of high enzyme activity, trypsinogen degradation capacity, and protection against pancreatitis.

Authors:  Bálint Zoltán Németh; Alexandra Demcsák; András Micsonai; Bence Kiss; Gitta Schlosser; Andrea Geisz; Eszter Hegyi; Miklós Sahin-Tóth; Gábor Pál
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2022-08-05       Impact factor: 4.125

5.  The catalytic aspartate is protonated in the Michaelis complex formed between trypsin and an in vitro evolved substrate-like inhibitor: a refined mechanism of serine protease action.

Authors:  Weixiao Yuan Wahlgren; Gábor Pál; József Kardos; Pálma Porrogi; Borbála Szenthe; András Patthy; László Gráf; Gergely Katona
Journal:  J Biol Chem       Date:  2010-11-21       Impact factor: 5.157

6.  Identification, distribution and molecular evolution of the pacifastin gene family in Metazoa.

Authors:  Bert Breugelmans; Gert Simonet; Vincent van Hoef; Sofie Van Soest; Jozef Vanden Broeck
Journal:  BMC Evol Biol       Date:  2009-05-12       Impact factor: 3.260

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.